Grant Details

GRANT OVERVIEW

Grant name and funding organization

Limited Competition: Small Grant Program for NHLBI K01/K08/K23/K25 Recipients

National Institutes of Health (NIH)

Total funding amount and duration

Maximum funding amount: $75,000

Project duration: Up to 2 years

Primary objective and mission statement

To support current or recently completed NHLBI K awardees in expanding their research objectives or branching out to new studies.

To enhance the capability of NHLBI K awardees to conduct research as they transition to fully independent investigator status.

Key stakeholders and beneficiaries

Current and recently completed NHLBI K01, K08, K23, and K25 awardees.

The broader biomedical research community.

ELIGIBILITY CRITERIA

Organization Requirements

Eligible organization types include higher education institutions, nonprofits, for-profit organizations, local and state governments, and tribal governments.

Non-domestic (non-U.S.) entities are not eligible to apply.

Geographic Scope

Only U.S.-based organizations are eligible.

Non-domestic components of U.S. organizations are not eligible.

Project Requirements

Projects must be completed within two years.

Research types include pilot studies, proof of concept studies, secondary analysis of existing data, and development of new methodologies.

Financial Requirements

Direct costs are limited to $75,000 per year.

No cost-sharing is required.

Timeline Requirements

Application due date: January 7, 2026.

Earliest submission date: January 13, 2025.

Previous Funding Considerations

Applicants who have previously received substantial NIH independent research awards are ineligible.

APPLICATION PROCESS

Required documentation and materials

Applications must include a summary of the applicant's funded K award.

Letters of support from mentors and institutional commitment are required.

Evaluation criteria and scoring system

Applications will be evaluated based on significance, innovation, rigor, and feasibility.

Review process and timeline

Applications will undergo peer review and receive a written critique.

Selection criteria and priorities

Scientific and technical merit of the proposed project will be the primary selection criterion.

SPECIAL CONSIDERATIONS

Unique aspects or requirements

A minimum of 40% protected research effort is required from applicants.

Potential challenges or limitations

Non-domestic entities are not eligible, which may limit collaboration opportunities.

Strategic alignment opportunities

Projects should align with NHLBI's mission to support cardiovascular, lung, and blood diseases research.

Competitive advantages or disadvantages

The program supports early-stage investigators transitioning to independent research, which may enhance competitiveness for future funding.

KEY INSIGHTS AND RECOMMENDATIONS

Critical success factors

Demonstrating a clear plan for how the R03 project builds on the K award.

Common pitfalls to avoid

Submitting applications that do not comply with the detailed instructions in the application guide.

Strategic recommendations for applicants

Engage mentors and institutional support early in the application process.

Competitive positioning advice

Highlight previous K award successes and how the R03 will enhance future research independence.

Grant Details

research health biomedical research clinical trials small grant NHLBI K awards independent research pilot studies proof of concept
Limited Competition: Small Grant Program for NHLBI K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
RFA-HL-25-011
NIH Grants
UNIVERSITY NGO PUBLIC ENTERPRISE OTHER
US
RESEARCH_DEVELOPMENT
False
75000.00
None
75000.00
USD
100.00
True
False
Enhance the capability of NHLBI K awardees to conduct research and transition to independent investigator status.
Preliminary data to support subsequent R01-equivalent applications.
Jan. 7, 2026, 10 p.m.
March 2026
Summary of K award progress, letters of support, research strategy.
True
Overall impact score based on significance, innovation, rigor, and feasibility.
Significance and innovation of the proposed research.
Rigor and feasibility of the proposed approach.
Potential for sustained impact on the research field.
False
False
Grant
Compliance with NIH Grants Policy Statement.
Annual progress reports and financial statements.
Payments contingent upon compliance with reporting requirements.
NIH Grants Policy Statement and federal regulations.
None specified.